June 4, 2023
2 mins read

Shortage forces US to import Chinese cancer drug

Cisplatin, a generic drug available for decades in the US, has faced national shortage since February…reports Asian Lite News

In a bid to ease the ongoing shortage of chemotherapy in the US, the country’s Food and Drug Administration (FDA) has allowed for a temporary import of the cancer drug made in China.

Chinese drug maker Qilu Pharmaceutical has received the FDA approval for their cisplatin injections, CNBC reported.

The injectable medication will be distributed in the US in 50-milligram vials on a temporary basis by Canadian drug maker Apotex. It will be available for order by health care providers starting Tuesday.

“The FDA recognises the importance of a stable, safe supply of critical drugs used in oncology, especially those used in potentially curative or life-extending situations,” FDA Commissioner Dr Robert Califf said on Twitter.

“Today, we’ve taken steps for temporary importation of certain foreign-approved versions of cisplatin products from FDA-registered facilities and used regulatory discretion for continued supply of other cisplatin and carboplatin products to help meet patient needs.

“In these situations, we very carefully assess product quality and require companies to take certain measures to ensure the products are safe for patients. The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” he noted.

High-Fibre Diet May Lower Colon Cancer Risk

Cisplatin, a generic drug available for decades in the US, has faced national shortage since February after an Indian pharmaceutical company temporarily halted production for the US market.

According to the US National Cancer Institute, Cisplatin and other platinum-based drugs are prescribed for 10 per cent to 20 per cent of all cancer patients. Cisplatin has a cure rate of over 90 per cent when used to treat testicular cancer. It also treats bladder, cervical, ovarian, lung, gastric, breast, and head and neck cancers.

The severe shortage of cisplatin and carboplatin, “the chemotherapy backbone”, is affecting hundreds of thousands of patients across the US, Dr. Amanda Fader, a professor at the Johns Hopkins School of Medicine, was quoted as saying to CNN.

Qilu’s version of cisplatin is not approved in the US. An FDA spokesperson said the agency assesses the quality of unapproved drug imports to make sure they are safe for US patients. At least 13 other cancer drugs are in short supply across the US.

ALSO READ: China ‘weaponsing’ investment on foreign soil

Previous Story

India, Maldives ink 10 MoUs to cement ties

Next Story

Australian PM in Vietnam to bolster ties

Latest from -Top News

GAZA KILLINGS: War Crime?

Mobile Phone Footage Casts Doubt on Israeli Account of Ambulance Attack in Gaza Newly surfaced mobile phone footage has raised serious questions about the Israeli military’s justification for opening fire on a

Namibia voices concern over US tariffs

AGOA is a non-reciprocal trade arrangement aimed at supporting development in African countries through preferential access to US markets The Namibian government has expressed concern over newly imposed US tariffs, warning that

Uganda, South Sudanese leaders hold talks

Museveni, who is among the guarantors of a 2018 peace agreement that ended a five-year civil war, held closed-door discussions with President Salva Kiir Uganda’s President Yoweri Museveni was expected to meet

Protests across US against Trump

The largest event was at the National Mall in DC, where demonstrators numbered in the tens of thousands People across the US took to the streets on Saturday to oppose what left-leaning

Namibia voices concern over US tariffs

AGOA is a non-reciprocal trade arrangement aimed at supporting development in African countries through preferential access to US markets The Namibian government has expressed concern over newly imposed US tariffs, warning that
Go toTop

Don't Miss

US will narrowly avoid recession: IMF chief

IMF chief Kristalina Georgieva highlighted “significant downside risks” this year

‘Born out of shared beliefs’: Biden on South Korea ties

Biden posted the comment as Yoon was on his way